Valeant Providing Reporters With an Earnings Metric the SEC Ordered it to Stop Using Post author:Sam Post published:November 9, 2017 Post category:BioPharma Valeant is not the only company to recently push reporters to defy the SEC’s orders. Source: BioSpace You Might Also Like Achaogen Adds As Chief Business Officer September 17, 2017 Acorda Investor Urges for Company to Explore Sale August 6, 2017 These 3 Gene Therapy Biotechs Could Make Investors Rich October 22, 2017
